The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions-Reference-Cited by-同舟云学术

The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions

Published:2021-07-27 Issue:5 Volume:43 Page:562-570
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Tahmasebi Safa¹,Neishaboori Hassan²,Jafari Davood³⁴,Faghihzadeh Elham⁵,Esmaeilzadeh Abdolreza³⁴,Mirshafiey Abbas¹⁶

Affiliation:

1. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Internal Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

3. Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

4. Immunotherapy Research and Technology Group, Zanjan University of Medical Sciences, Zanjan, Iran

5. Department of Epidemiology and Biostatics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

6. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2021.1954946

Reference49 articles.

1. Non-alcoholic fatty liver disease

2. Non-alcoholic fatty liver disease

3. Nonalcoholic Fatty Liver Disease

4. Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond

5. Genetic predisposition in nonalcoholic fatty liver disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guluronic acid can inhibit copper(II) and amyloid − β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease;Journal of Inorganic Biochemistry;2023-08

2. The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients;Current Drug Discovery Technologies;2023-07